David Silberstein
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
-
- Cardiac electrophysiology and arrhythmias
- Blood Pressure and Hypertension Studies
- Heart Rate Variability and Autonomic Control
- Cardiac Arrhythmias and Treatments
Papers in
-
- Receptor Mechanisms and Signaling 4
- Ion channel regulation and function 2
-
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmacogenetics and Drug Metabolism 2
- Co-authors
- Alastair J.J. Wood (3 shared papers)Richard P. Koshakji (2 shared papers)G. Wilkinson (1 shared paper)Hong‐Hao Zhou (1 shared paper)Raymond L. Woosley (2 shared papers)Christian Funck‐Brentano (2 shared papers)Dan M. Roden (2 shared papers)Michel Eichelbaum (1 shared paper)
- Journals
- Journal of Pharmacy and Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)Clinical Pharmacology & Therapeutics (2 papers)New England Journal of Medicine (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesUnited KingdomTaiwan
In The Last Decade
David Silberstein
14 papers receiving 474 citations
Peers
Comparison fields: 5 of 87
- Pharmacology 134
- Cardiology and Cardiovascular Medicine 179
- Analytical Chemistry 36
- Pharmacology 45
- Pediatrics, Perinatology and Child Health 51
Countries citing papers authored by David Silberstein
This map shows the geographic impact of David Silberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Silberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Silberstein more than expected).
Fields of papers citing papers by David Silberstein
This network shows the impact of papers produced by David Silberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Silberstein. The network helps show where David Silberstein may publish in the future.
Co-authors
The 25 scholars most cited alongside David Silberstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 196 | |
| 2 | 1989 | 92 | |
| 3 | 1990 | 91 | |
| 4 | 1990 | 53 | |
| 5 | 1989 | 17 | |
| 6 | 2009 | 14 | |
| 7 | 2011 | 7 | |
| 8 | 2019 | 5 | |
| 9 | 1986 | 4 | |
| 10 | 1987 | 3 | |
| 11 | 1989 | 3 | |
| 12 | 1988 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2021 | 1 | |
| 15 | 2025 | 0 |
About David Silberstein
David Silberstein is a scholar working on Molecular Biology, Pharmacology, Genetics, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 490 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Glioma Diagnosis and Treatment (3 papers), Pharmacogenetics and Drug Metabolism (2 papers), Ion channel regulation and function (2 papers), Radiation Therapy and Dosimetry (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Pharmacological Effects and Assays (2 papers). The work is most often cited by research in Pharmacology (134 citations), Cardiology and Cardiovascular Medicine (179 citations), Analytical Chemistry (36 citations), Pharmacology (45 citations) and Pediatrics, Perinatology and Child Health (51 citations). David Silberstein has collaborated with scholars based in United States, United Kingdom and Taiwan. Frequent co-authors include Alastair J.J. Wood, Richard P. Koshakji, G. Wilkinson, Hong‐Hao Zhou, Raymond L. Woosley, Christian Funck‐Brentano, Dan M. Roden, Michel Eichelbaum, H K Kroemer and A J Wood. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Journal of Clinical Oncology, Clinical Pharmacology & Therapeutics, New England Journal of Medicine and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.